| Dr Joanna Younker, DO | |
|
2511 W Edgewood Dr Ste G, Jefferson City, MO 65109-5869 | |
| (573) 761-0458 | |
| (573) 761-6957 |
| Full Name | Dr Joanna Younker |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 2511 W Edgewood Dr Ste G, Jefferson City, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114278124 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2017020529 (Missouri) | Primary |
| 207Q00000X | Family Medicine | OS 12551 (Florida) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Missouri Home Health | Jefferson city, MO | Home health agency |
| Ssm Health St Mary's Hospital Jefferson City | Jefferson city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ssm Regional Health Services | 8921917352 | 55 |
News Archive
As part of an initiative to give back to cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is recognizing The Center for Cancer Support and Education (The Center) in Arlington, Mass., for its efforts to empower and support people touched by cancer, their caregivers and loved ones.
Researchers at The George Washington University Department of Health Policy have found through analysis of federal survey data that more than four in five office-based physicians could qualify for new, federal Medicare and Medicaid Electronic Health Record Incentive Programs under the Health Information Technology for Economic and Clinical Health portion of the American Recovery and Reinvestment Act of 2009.
Icahn School of Medicine at Mount Sinai researchers have linked high levels of exposure to inhaled particulate matter by first responders at Ground Zero to the risk of obstructed sleep apnea and post-traumatic stress disorder (PTSD), both conditions that may impact cardiovascular health.
A new study by researchers at Imperial College London, UK, discusses the effect of a vaccine dose, specifically the BNT162b2 candidate (also known as the ‘Pfizer-BioNTech' vaccine), on neutralizing antibody titers in individuals who have already been infected with the virus.
Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Naratriptan Tablets USP, 1mg and 2.5mg by the U.S. Food and Drug Administration. The product is available in bottles of 9 for immediate shipment to wholesalers and pharmacies nationwide.
› Verified 1 days ago
| Entity Name | Ssm Regional Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952357352 PECOS PAC ID: 8921917352 Enrollment ID: O20040819000270 |
News Archive
As part of an initiative to give back to cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is recognizing The Center for Cancer Support and Education (The Center) in Arlington, Mass., for its efforts to empower and support people touched by cancer, their caregivers and loved ones.
Researchers at The George Washington University Department of Health Policy have found through analysis of federal survey data that more than four in five office-based physicians could qualify for new, federal Medicare and Medicaid Electronic Health Record Incentive Programs under the Health Information Technology for Economic and Clinical Health portion of the American Recovery and Reinvestment Act of 2009.
Icahn School of Medicine at Mount Sinai researchers have linked high levels of exposure to inhaled particulate matter by first responders at Ground Zero to the risk of obstructed sleep apnea and post-traumatic stress disorder (PTSD), both conditions that may impact cardiovascular health.
A new study by researchers at Imperial College London, UK, discusses the effect of a vaccine dose, specifically the BNT162b2 candidate (also known as the ‘Pfizer-BioNTech' vaccine), on neutralizing antibody titers in individuals who have already been infected with the virus.
Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Naratriptan Tablets USP, 1mg and 2.5mg by the U.S. Food and Drug Administration. The product is available in bottles of 9 for immediate shipment to wholesalers and pharmacies nationwide.
› Verified 1 days ago
| Entity Name | Ssm Regional Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659327393 PECOS PAC ID: 8921917352 Enrollment ID: O20050322000373 |
News Archive
As part of an initiative to give back to cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is recognizing The Center for Cancer Support and Education (The Center) in Arlington, Mass., for its efforts to empower and support people touched by cancer, their caregivers and loved ones.
Researchers at The George Washington University Department of Health Policy have found through analysis of federal survey data that more than four in five office-based physicians could qualify for new, federal Medicare and Medicaid Electronic Health Record Incentive Programs under the Health Information Technology for Economic and Clinical Health portion of the American Recovery and Reinvestment Act of 2009.
Icahn School of Medicine at Mount Sinai researchers have linked high levels of exposure to inhaled particulate matter by first responders at Ground Zero to the risk of obstructed sleep apnea and post-traumatic stress disorder (PTSD), both conditions that may impact cardiovascular health.
A new study by researchers at Imperial College London, UK, discusses the effect of a vaccine dose, specifically the BNT162b2 candidate (also known as the ‘Pfizer-BioNTech' vaccine), on neutralizing antibody titers in individuals who have already been infected with the virus.
Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Naratriptan Tablets USP, 1mg and 2.5mg by the U.S. Food and Drug Administration. The product is available in bottles of 9 for immediate shipment to wholesalers and pharmacies nationwide.
› Verified 1 days ago
| Entity Name | Ssm Regional Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831288869 PECOS PAC ID: 8921917352 Enrollment ID: O20070118000135 |
News Archive
As part of an initiative to give back to cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is recognizing The Center for Cancer Support and Education (The Center) in Arlington, Mass., for its efforts to empower and support people touched by cancer, their caregivers and loved ones.
Researchers at The George Washington University Department of Health Policy have found through analysis of federal survey data that more than four in five office-based physicians could qualify for new, federal Medicare and Medicaid Electronic Health Record Incentive Programs under the Health Information Technology for Economic and Clinical Health portion of the American Recovery and Reinvestment Act of 2009.
Icahn School of Medicine at Mount Sinai researchers have linked high levels of exposure to inhaled particulate matter by first responders at Ground Zero to the risk of obstructed sleep apnea and post-traumatic stress disorder (PTSD), both conditions that may impact cardiovascular health.
A new study by researchers at Imperial College London, UK, discusses the effect of a vaccine dose, specifically the BNT162b2 candidate (also known as the ‘Pfizer-BioNTech' vaccine), on neutralizing antibody titers in individuals who have already been infected with the virus.
Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Naratriptan Tablets USP, 1mg and 2.5mg by the U.S. Food and Drug Administration. The product is available in bottles of 9 for immediate shipment to wholesalers and pharmacies nationwide.
› Verified 1 days ago
| Entity Name | Ssm Regional Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396886065 PECOS PAC ID: 8921917352 Enrollment ID: O20070316000022 |
News Archive
As part of an initiative to give back to cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is recognizing The Center for Cancer Support and Education (The Center) in Arlington, Mass., for its efforts to empower and support people touched by cancer, their caregivers and loved ones.
Researchers at The George Washington University Department of Health Policy have found through analysis of federal survey data that more than four in five office-based physicians could qualify for new, federal Medicare and Medicaid Electronic Health Record Incentive Programs under the Health Information Technology for Economic and Clinical Health portion of the American Recovery and Reinvestment Act of 2009.
Icahn School of Medicine at Mount Sinai researchers have linked high levels of exposure to inhaled particulate matter by first responders at Ground Zero to the risk of obstructed sleep apnea and post-traumatic stress disorder (PTSD), both conditions that may impact cardiovascular health.
A new study by researchers at Imperial College London, UK, discusses the effect of a vaccine dose, specifically the BNT162b2 candidate (also known as the ‘Pfizer-BioNTech' vaccine), on neutralizing antibody titers in individuals who have already been infected with the virus.
Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Naratriptan Tablets USP, 1mg and 2.5mg by the U.S. Food and Drug Administration. The product is available in bottles of 9 for immediate shipment to wholesalers and pharmacies nationwide.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joanna Younker, DO 2511 W Edgewood Dr Ste G, Jefferson City, MO 65109-5869 Ph: (573) 761-0458 | Dr Joanna Younker, DO 2511 W Edgewood Dr Ste G, Jefferson City, MO 65109-5869 Ph: (573) 761-0458 |
News Archive
As part of an initiative to give back to cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is recognizing The Center for Cancer Support and Education (The Center) in Arlington, Mass., for its efforts to empower and support people touched by cancer, their caregivers and loved ones.
Researchers at The George Washington University Department of Health Policy have found through analysis of federal survey data that more than four in five office-based physicians could qualify for new, federal Medicare and Medicaid Electronic Health Record Incentive Programs under the Health Information Technology for Economic and Clinical Health portion of the American Recovery and Reinvestment Act of 2009.
Icahn School of Medicine at Mount Sinai researchers have linked high levels of exposure to inhaled particulate matter by first responders at Ground Zero to the risk of obstructed sleep apnea and post-traumatic stress disorder (PTSD), both conditions that may impact cardiovascular health.
A new study by researchers at Imperial College London, UK, discusses the effect of a vaccine dose, specifically the BNT162b2 candidate (also known as the ‘Pfizer-BioNTech' vaccine), on neutralizing antibody titers in individuals who have already been infected with the virus.
Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Naratriptan Tablets USP, 1mg and 2.5mg by the U.S. Food and Drug Administration. The product is available in bottles of 9 for immediate shipment to wholesalers and pharmacies nationwide.
› Verified 1 days ago
Todd D Mccluskey, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3308 W Edgewood Dr, Suite B, Jefferson City, MO 65109 Phone: 573-893-7848 Fax: 573-893-1984 | |
Craig Alan Luetkemeyer, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1014 Madison St, Jefferson City, MO 65101 Phone: 573-644-6999 Fax: 573-644-7880 | |
Dr. Michael G. Steenbergen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-635-5264 Fax: 573-634-7423 | |
Dr. James J. Weiss, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-635-5264 Fax: 573-634-7423 | |
Lorrie L Campbell, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1014 Madison St, Jefferson City, MO 65101 Phone: 573-644-6999 Fax: 573-644-7880 | |
Dr. Douglas N. Smith, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3308 W Edgewood Dr, Suite B, Jefferson City, MO 65109 Phone: 573-893-7848 Fax: 573-893-1984 | |
Michael Peter Dudenhoeffer, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 606 E High St, Jefferson City, MO 65101 Phone: 573-635-2211 Fax: 573-636-9350 |